𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gefitinib (Iressa) Potentiates the Effect of Ionizing Radiation in Thyroid Cancer Cell Lines

✍ Scribed by Jay Patrick Lopez; Jessica Wang-Rodriguez; Catherine Y. Chang; Gabriel Sneh; Michael Andrew Yu; Francisco S. Pardo; Joseph Aguilera; Weg M. Ongkeko

Book ID
110089274
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
259 KB
Volume
118
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tumor inhibitory effect of gefitinib (ZD
Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231)
✍ Daisuke Takabatake; Takeo Fujita; Tadahiko Shien; Kensuke Kawasaki; Naruto Taira πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 588 KB

## Abstract Some kinds of breast cancer cell lines, similar to several types of solid tumors, express epidermal growth factor receptor (EGFR). However, gefitinib, an EGFR tyrosine kinase inhibitor, is not effective for all these cell lines. Similarly, taxane is effective for many of the cell lines,

Additive antitumor effects of the epider
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro
✍ Claudio Festuccia; Giovanni Luca Gravina; Adriano Angelucci; Danilo Millimaggi; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 618 KB

## Abstract Progression from an androgen‐dependent to an androgen‐independent state often occurs in patients with prostate cancer (PCa) who undergo hormonal therapy. We have investigated whether inhibition of the epidermal growth factor receptor (EGFR) signaling pathway affects the antitumor effect